|
116
|
348
|
6a32A |
Crystal structure of pdgfra kinase domain mutant t674i |
|
27
|
88
|
5z02A |
Crystal structure of his6-tagged mdm2 with nutlin-3a |
|
58
|
166
|
821pA |
Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21h-ras |
|
38
|
145
|
6gmnI |
Pvhl:elob:eloc in complex with methyl 4h-furo[3,2-b]pyrrole-5-carboxylate |
|
25
|
95
|
6gmqB |
Pvhl:elob:eloc in complex with (4-(1h-pyrrol-1-yl)phenyl)methanol |
|
23
|
103
|
6gmnA |
Pvhl:elob:eloc in complex with methyl 4h-furo[3,2-b]pyrrole-5-carboxylate |
|
31
|
140
|
6gmnC |
Pvhl:elob:eloc in complex with methyl 4h-furo[3,2-b]pyrrole-5-carboxylate |
|
22
|
103
|
6gmqA |
Pvhl:elob:eloc in complex with (4-(1h-pyrrol-1-yl)phenyl)methanol |
|
26
|
96
|
6gmnB |
Pvhl:elob:eloc in complex with methyl 4h-furo[3,2-b]pyrrole-5-carboxylate |
|
24
|
102
|
6gmnD |
Pvhl:elob:eloc in complex with methyl 4h-furo[3,2-b]pyrrole-5-carboxylate |
|
30
|
139
|
6gmqC |
Pvhl:elob:eloc in complex with (4-(1h-pyrrol-1-yl)phenyl)methanol |
|
23
|
95
|
6gmxE |
Pvhl:elob:eloc in complex with 6-chlorothiochroman-4-one |
|
25
|
96
|
6gmxB |
Pvhl:elob:eloc in complex with 6-chlorothiochroman-4-one |
|
33
|
140
|
6gmxC |
Pvhl:elob:eloc in complex with 6-chlorothiochroman-4-one |
|
19
|
101
|
6gmxD |
Pvhl:elob:eloc in complex with 6-chlorothiochroman-4-one |
|
21
|
96
|
6gmqH |
Pvhl:elob:eloc in complex with (4-(1h-pyrrol-1-yl)phenyl)methanol |
|
24
|
103
|
6gmxA |
Pvhl:elob:eloc in complex with 6-chlorothiochroman-4-one |
|
62
|
172
|
6f76A |
Antibody derived (abd-8) small molecule binding to kras. |
|
64
|
172
|
6fa4A |
Antibody derived (abd-7) small molecule binding to kras. |
|
63
|
171
|
6fa3A |
Antibody derived (abd-6) small molecule binding to kras. |
|
85
|
296
|
6fekA |
Oncogenic point mutation of ret receptor tyrosine kinase |
|
61
|
171
|
6fa2C |
Antibody derived (abd-5) small molecule binding to kras. |
|
63
|
172
|
6fa3B |
Antibody derived (abd-6) small molecule binding to kras. |
|
62
|
173
|
6fa4B |
Antibody derived (abd-7) small molecule binding to kras. |
|
65
|
172
|
6fa1A |
Antibody derived (abd-4) small molecule binding to kras. |
|
60
|
167
|
6fa2A |
Antibody derived (abd-5) small molecule binding to kras. |
|
64
|
173
|
6fa1E |
Antibody derived (abd-4) small molecule binding to kras. |
|
65
|
173
|
6fa1B |
Antibody derived (abd-4) small molecule binding to kras. |
|
62
|
170
|
6fa2B |
Antibody derived (abd-5) small molecule binding to kras. |
|
6
|
47
|
5yufA |
Crystal structure of pml ring tetramer |
|
96
|
318
|
5yu9A |
Crystal structure of egfr 696-1022 t790m in complex with ibrutinib |
|
13
|
85
|
5z55A |
Nmr solution structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (ror1) |
|
32
|
189
|
5zhxe |
Crystal structure of smggds-558 and farnesylated rhoa complex |
|
159
|
469
|
5zhxA |
Crystal structure of smggds-558 and farnesylated rhoa complex |
|
36
|
166
|
5zc6A |
Solution structure of h-rast35s mutant protein in complex with kbfm123 |
|
42
|
149
|
5yawB |
Fragment-based drug discovery of inhibitors to block pdedelta-ras protein-protein interaction |
|
180
|
480
|
5xgcA |
Crystal structure of smggds-558 |
|
64
|
166
|
5b30A |
H-ras wt in complex with gppnhp (state 1) after structural transition by humidity control |
|
173
|
522
|
4dvzA |
Crystal structure of the helicobacter pylori caga oncoprotein |
|
235
|
801
|
4dvyP |
Crystal structure of the helicobacter pylori caga oncoprotein |
|
41
|
149
|
5yavB |
Fragment-based drug discovery of inhibitors to block pdedelta-ras protein-protein interaction |
|
60
|
166
|
5x9sA |
Crystal structure of fully modified h-ras-gppnhp |
|
61
|
184
|
5tb5A |
Crystal structure of full-length farnesylated and methylated kras4b in complex with pde-delta (crystal form i - with partially disordered hypervariable region) |
|
45
|
150
|
5tb5B |
Crystal structure of full-length farnesylated and methylated kras4b in complex with pde-delta (crystal form i - with partially disordered hypervariable region) |
|
42
|
148
|
5tarB |
Crystal structure of farnesylated and methylated kras4b in complex with pde-delta (crystal form ii - with ordered hypervariable region) |
|
69
|
184
|
5tarA |
Crystal structure of farnesylated and methylated kras4b in complex with pde-delta (crystal form ii - with ordered hypervariable region) |
|
136
|
542
|
5o4gC |
Her2 in complex with fab mf3958 |
|
41
|
214
|
5o4gA |
Her2 in complex with fab mf3958 |
|
29
|
216
|
5o4gB |
Her2 in complex with fab mf3958 |
|
63
|
166
|
5b2zA |
H-ras wt in complex with gppnhp (state 2*) before structural transition by humidity control |
